4.6 Article

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study

Journal

EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 189, Issue 6, Pages 601-610

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ejendo/lvad164

Keywords

anabolic-androgenic steroids; androgens; hypogonadism; post-cycle therapy; testosterone; withdrawal

Ask authors/readers for more resources

This study investigated whether prior post-cycle therapy (PCT) use was associated with the normalization of reproductive hormones following anabolic-androgenic steroid (AAS) cessation. The results showed that PCT use was associated with faster biochemical recovery, but only about half of the men had complete restoration of testicular function after stopping AAS.
Objective Symptomatic hypogonadism discourages men from stopping anabolic-androgenic steroids (AAS). Some men illicitly take drugs temporarily stimulating endogenous testosterone following AAS cessation (post-cycle therapy; PCT) to lessen hypogonadal symptoms. We investigated whether prior PCT use was associated with the normalization of reproductive hormones following AAS cessation. Methods Retrospective analysis of 641 men attending a clinic between 2015-2022 for a single, nonfasting, random blood test <36 months following AAS cessation, with or without PCT. Normalized reproductive hormones (ie, a combination of reference range serum luteinizing hormone, follicle-stimulating hormone, and total testosterone levels) were the surrogate marker of biochemical recovery. Results Normalization of reproductive hormones was achieved in 48.2% of men. PCT use was associated with faster biochemical recovery (13.0 (IQR8.0-19.0) weeks, PCT; 26.0 (IQR10.5-52) weeks, no-PCT; P < .001). Odds of biochemical recovery during multivariable analysis were: (1) higher with PCT (OR3.80) vs no-PCT (P = .001), in men stopping AAS <= 3 months previously; (2) reduced when 2 (OR0.55), 3 (OR0.46), or 4 (OR0.25) AAS were administered vs 1 drug (P = .009); (3) lower with AAS >6 vs <= 3 months previously (OR0.34, P = .01); (4) higher with last reported AAS >3 months (OR 5.68) vs <= 3 months (P = .001). PCT use was not associated with biochemical recovery in men stopping AAS >3 months previously. Conclusion Without evidence-based withdrawal protocols, men commonly try avoiding post-AAS hypogonadism with PCT, which is illicit, ill-defined, and not recommended. Only half of men had complete biochemical testicular recovery after stopping AAS. The surprising association of self-reported PCT use with short-term biochemical recovery from AAS-induced hypogonadism warrants further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available